Analysis of the ΔF508 mutation in a Brazilian cystic fibrosis population: Comparison of pulmonary status of homozygotes with other patients

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 4, 1998, Pages 529-532

  Marostica P J C ^a   Raskin, S ^b,c   Abreu e Silva, F A ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Cystic fibrosis; Genotype; Phenotype; F508 gene mutation

Indexed keywords

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

PHENYLALANINE;

ADOLESCENT; ARTICLE; BRAZIL; CHILD; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CYSTIC FIBROSIS; FEMALE; GENETICS; HOMOZYGOTE; HUMAN; INFANT; LUNG; LUNG FUNCTION TEST; MALE; MUTATION; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RISK; STATISTICAL MODEL;

ADOLESCENT; BRAZIL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; HOMOZYGOTE; HUMANS; INFANT; LOGISTIC MODELS; LUNG; MALE; MUTATION; ODDS RATIO; PHENYLALANINE; RESPIRATORY FUNCTION TESTS;

EID: 0032039748     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000400009     Document Type: Article

References (27)

1. Mearns MB (1993). Cystic fibrosis: the first 50 years, a review of the clinical problems and their management. In: Dodge JA, Brock DJH & Widdicombe JH (Editors), Cystic Fibrosis Current Topics. John Wiley and Sons, Chichester.
2. Riordan JR, Rommens JM, Kerem BS, Alon N, Rozmahel R, Grzelczak Z, Zielenski J, Lok L, Plavsik N, Chou JL, Drumm ML, Ianuzzi MC, Collins FS & Tsui LC (1989). Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science, 245: 1066-1073.
3. Kerem BS, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M & Tsui LC (1989). Identification of the cystic fibrosis gene: genetic analysis. Science, 245: 1073-1080.
4. Rommens JM, Ianuzzi MC, Kerem BS, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordan JR, Tsui LC & Collins F (1989). Identification of the cystic fibrosis gene: chromosome walking and jumping. Science, 245: 1059-1065
5. Hamosh A & Cutting GR (1993). Genotype/phenotype relationships in cystic fibrosis. In: Dodge JA, Brock DJH & Widdicombe JH (Editors), Cystic Fibrosis Current Topics. John Wiley and Sons, Chichester.
6. Pignatti PF (1991). Cystic fibrosis gene mutations and correlation with clinical manifestations. Pathologie Biologie, 39: 582-584.
7. Santis G, Osborne L, Knight RA & Hodson ME (1990). Linked marker haplotypes and the ΔF508 mutation in adults with mild pulmonary disease and cystic fibrosis. Lancet, 335: 1426-1429.
8. Lanng S, Schwartz M, Thorsteinsson B & Koch C (1991). Endocrine and exocrine pancreatic function and the ΔF508 mutation in cystic fibrosis. Clinical Genetics, 40: 345-348.
9. Kerem E, Corey M, Kerem BS, Rommens J, Markiewicz D, Levison H, Tsui LC & Durie P (1990). The relation between genotype and phenotype in cystic fibrosis - analysis of the most common mutation (ΔF508). New England Journal of Medicine, 323: 1517-1522.
10. Santis G, Osboine L, Knight R & Hodson ME (1990). Independent genetic determinants of pancreatic and pulmonary status m cystic fibrosis. Lancet, 336: 1081-1084.
11. The Cystic Fibrosis Genotype-Phenotype Consortium (1993), Correlation between genotype and phenotype in patients with cystic fibrosis. New England Journal of Medicine, 329: 1308-1313.
12. Rosenstein BJ (1994). Genotype-phenotype correlations in cystic fibrosis. Lancet, 343: 746-747.
13. Gan K-H, Veeze HJ, Ouweland MW, Halley DJJ, Scheffer H, Hout A, Overbeek SE, Jongste JC, Bakker W & Heijerman HGM (1995). A cystic fibrosis mutation associated with mild lung disease. New England Journal of Medicine, 333: 95-99.
14. Alton EWFW (1996). A mild variant of cystic fibrosis. Thorax, 51 (Suppl 2): S51-S54.
15. Doershuk CF, Matthews LW, Tucker AS, Nudelman H, Eddy G, Wise M & Spector S (1964). A 5 year clinical evaluation therapeutic program for patients with cystic fibrosis. Journal of Pediatrics, 65: 677-693.
16. Chrispin AR & Norman AP (1974). The systematic evaluation of the chest radiograph in cystic fibrosis. Pediatric Radiology, 2: 101-106.
17. Sinniah D & Omar A (1979). Quantitation of digital clubbing by shadowgram technique. Archives of Diseases in Childhood, 54: 145-146.
18. Wilmott RW, Tyson SL & Matthew DJ (1985). Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa. American Journal of Diseases in Children, 139: 669-671.
19. Campbell III PW & Phillips III JA (1992). The cystic fibrosis gene and relationships to clinical status. Seminars in Respiratory Infections, 7: 150-157.
20. Campbell III PW, Phillips III JA, Krishnamani MRS, Maness KJ & Hazinski TA (1991). Cystic fibrosis: relationship between clinical status and F508 deletion. Journal of Pediatrics, 118: 239-241.
21. Burke W, Aitken ML, Chen SH & Scott R (1992). Variable severity in pulmonary disease in adults with identical cystic fibrosis mutations. Chest, 102: 506-509.
22. Al-Jader LN, Meredith AL, Ryley HC, Cheadle JP, Maguire S, Owen G, Goodchild MC & Harper PS (1992). Severity of chest disease in cystic fibrosis patients in relation to their genotypes. Journal of Medical Genetics, 29: 883-887.
23. O'Rawe A, McIntosh I, Dodge JA, Brock DJH, Redmond AOB, Ward R & MacPherson JS (1992). Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clinical Science, 82: 71-76.
24. Packe GE, Miedzybrodska ZH, Russel G, Friend JAR, Haites NE, Kelly KF & Dean JCS (1992). Comparison of clinical features in cystic fibrosis patients with different genotypes. Thorax, 47:866 (Abstract).
25. Johansen HK, Nir M, Høfiby N, Koch C & Schwarts M (1991) Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet, 337: 631-634.
26. Liechti-Gallati S, Bonsall I, Malik N, Schneider V, Kraemer LG, Ruedeberg A, Moser H & Kraemer R (1992). Genotype/phenotype association in cystic fibrosis: analysis of the delta F508, R553X and 3905insT mutations. Pediatric Research, 32: 175-178.
27. BorgoG, Gasparini P, Bonizzato A, Cabrini G, Mastella G & Pignatti PF (1993). Cystic fibrosis: the delta F508 mutation does not lead to an exceptionally severe phenotype. A cohort study. European Journal of Pediatrics, 152: 1006-1011.